See more : SolarWorld Aktiengesellschaft (SWVK.F) Income Statement Analysis – Financial Results
Complete financial analysis of Theralink Technologies, Inc. (OBMP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Theralink Technologies, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- AXT, Inc. (AXTI) Income Statement Analysis – Financial Results
- The Allstate Corporation (ALL-PG) Income Statement Analysis – Financial Results
- NHC Foods Limited (NHCFOODS.BO) Income Statement Analysis – Financial Results
- First Brothers Co.,Ltd. (3454.T) Income Statement Analysis – Financial Results
- Sonasoft Corporation (SSFT) Income Statement Analysis – Financial Results
Theralink Technologies, Inc. (OBMP)
About Theralink Technologies, Inc.
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 505.60K | 181.23K | 0.00 | 0.00 | 0.00 | 0.00 | 74.00 | 24.00 | 77.94K | 781.05K | 266.81K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 117.46K | 52.59K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.36K | 219.44K | 85.56K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 388.15K | 128.64K | 0.00 | 0.00 | 0.00 | 0.00 | 74.00 | 24.00 | 25.58K | 561.61K | 181.25K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 76.77% | 70.98% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 32.82% | 71.90% | 67.93% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 166.72K | 204.56K | 103.92K | 94.38K | 85.32K | 151.26K | 0.00 | 0.00 | 12.05K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.95M | 3.49M | 1.60M | 1.57M | 2.36M | 1.71M | 160.91K | 516.79K | 611.47K | 1.13M | 893.62K | 56.13K | 53.59K | 60.16K | 50.58K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.14K | 338.97K | 254.92K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.95M | 3.49M | 1.60M | 1.57M | 2.36M | 1.71M | 160.91K | 516.79K | 644.61K | 1.47M | 1.15M | 56.13K | 53.59K | 60.16K | 50.58K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.32K | 17.44K | 86.49K | 88.28K | 51.50K | -112.26K | -107.18K | -120.32K | -101.17K |
| Operating Expenses | 5.95M | 3.49M | 1.77M | 1.78M | 2.46M | 1.80M | 213.23K | 534.23K | 731.10K | 1.56M | 1.21M | -56.13K | -53.59K | -60.16K | -50.58K |
| Cost & Expenses | 6.07M | 3.54M | 1.77M | 1.78M | 2.46M | 1.80M | 213.23K | 534.23K | 783.46K | 1.78M | 1.30M | 56.13K | 53.59K | 60.16K | 50.58K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 121.09K | 31.22K | 1.80M | 2.13M | 1.15M | 108.07K | 40.68K | 31.72K | 45.83K | 22.57K | 18.25K | 2.07K | 366.00 | 250.00 | 307.00 |
| Depreciation & Amortization | 185.73K | 97.76K | 2.34K | 2.34K | 3.94K | 1.10K | 52.32K | 17.44K | 86.49K | 88.28K | 51.50K | 0.00 | 0.00 | -5.00K | 0.00 |
| EBITDA | -5.16M | -3.04M | -7.60M | 8.60M | -19.36M | -1.90M | -330.42K | -708.25K | -183.62K | -841.69K | -979.34K | -56.13K | -53.59K | -65.16K | -50.58K |
| EBITDA Ratio | -1,021.52% | -1,678.15% | 0.00% | 0.00% | 0.00% | 0.00% | -446,518.92% | -2,951,029.17% | -235.60% | -107.76% | -367.06% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.35M | -3.14M | -7.61M | 8.60M | -19.36M | -1.91M | -382.74K | -725.69K | -270.11K | -929.98K | -1.03M | -56.13K | -53.59K | -60.16K | -50.58K |
| Operating Income Ratio | -1,058.25% | -1,732.09% | 0.00% | 0.00% | 0.00% | 0.00% | -517,221.62% | -3,023,695.83% | -346.57% | -119.07% | -386.36% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -121.09K | -31.22K | -1.80M | -2.13M | 4.51M | -108.07K | -150.13K | 159.77K | -45.83K | -22.57K | -18.25K | 0.00 | 0.00 | -5.00K | 0.00 |
| Income Before Tax | -5.47M | -3.17M | -9.40M | 6.47M | -14.85M | -2.01M | -532.87K | -565.92K | -315.94K | -952.54K | -1.05M | 0.00 | 0.00 | -65.16K | 0.00 |
| Income Before Tax Ratio | -1,082.20% | -1,749.32% | 0.00% | 0.00% | 0.00% | 0.00% | -720,094.59% | -2,358,008.33% | -405.37% | -121.96% | -393.20% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 121.09K | 31.22K | 1.80M | 2.13M | 1.15M | 108.07K | 40.68K | 31.72K | 45.83K | 22.57K | 18.25K | 58.20K | 53.96K | 5.00K | 50.89K |
| Net Income | -5.59M | -3.20M | -11.20M | 4.34M | -16.00M | -2.12M | -573.55K | -597.64K | -361.77K | -975.11K | -1.07M | -58.20K | -53.96K | -70.16K | -50.89K |
| Net Income Ratio | -1,106.15% | -1,766.54% | 0.00% | 0.00% | 0.00% | 0.00% | -775,063.51% | -2,490,158.33% | -464.17% | -124.85% | -400.04% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.04 | -0.02 | 0.01 | -93.12 | -27.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.04 | -0.02 | 0.01 | -93.12 | -27.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 5.37B | 84.66M | 494.84M | 311.73M | 171.85K | 77.72K | 602.00M | 602.00M | 598.00M | 598.00M | 598.00M | 588.00M | 588.00M | 287.00M | 287.00M |
| Weighted Avg Shares Out (Dil) | 5.37B | 84.66M | 494.84M | 708.17M | 171.85K | 77.72K | 602.00M | 602.00M | 598.00M | 598.00M | 598.00M | 588.00M | 588.00M | 287.00M | 287.00M |
AMC Is Winning the Keynesian Beauty Contest
Source: https://incomestatements.info
Category: Stock Reports